Kothari Sugars & Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 13, 2025, 8:08 pm

Quick Insight

Kothari Sugars & Chemicals Ltd's current market price of 31.8 with a P/E ratio of 36.8 suggests the stock may be overvalued compared to its industry peers. The company's low ROE and ROCE at 1.69% and 3.22% respectively indicate inefficiency in utilizing shareholder funds. Additionally, the OPM of 1.63% raises concerns about profitability. With a high promoter holding of 73.53% and low FII and DII ownership, the stock's liquidity could be impacted. The low P/BV ratio of 0.11x and weak ICR of 5.08x indicate potential financial risk. Investors should closely monitor the company's performance and financial health before considering investment, given the current metrics.

Competitors of Kothari Sugars & Chemicals Ltd

All Competitor Stocks of Kothari Sugars & Chemicals Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:00 am

Below is a detailed analysis of the quarterly data for Kothari Sugars & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 66.69 Cr.. The value appears strong and on an upward trend. It has increased from 36.05 Cr. (Mar 2025) to 66.69 Cr., marking an increase of 30.64 Cr..
• For Expenses, as of Jun 2025, the value is 65.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 38.91 Cr. (Mar 2025) to 65.60 Cr., marking an increase of 26.69 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.09 Cr.. The value appears strong and on an upward trend. It has increased from -2.86 Cr. (Mar 2025) to 1.09 Cr., marking an increase of 3.95 Cr..
• For OPM %, as of Jun 2025, the value is 1.63%. The value appears strong and on an upward trend. It has increased from -7.93% (Mar 2025) to 1.63%, marking an increase of 9.56%.
• For Other Income, as of Jun 2025, the value is 5.84 Cr.. The value appears to be declining and may need further review. It has decreased from 6.07 Cr. (Mar 2025) to 5.84 Cr., marking a decrease of 0.23 Cr..
• For Interest, as of Jun 2025, the value is 1.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.56 Cr. (Mar 2025) to 1.67 Cr., marking an increase of 1.11 Cr..
• For Depreciation, as of Jun 2025, the value is 3.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.66 Cr. (Mar 2025) to 3.62 Cr., marking a decrease of 0.04 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.64 Cr.. The value appears strong and on an upward trend. It has increased from -1.01 Cr. (Mar 2025) to 1.64 Cr., marking an increase of 2.65 Cr..
• For Tax %, as of Jun 2025, the value is 23.78%. The value appears to be increasing, which may not be favorable. It has increased from -31.68% (Mar 2025) to 23.78%, marking an increase of 55.46%.
• For Net Profit, as of Jun 2025, the value is 1.25 Cr.. The value appears strong and on an upward trend. It has increased from -0.69 Cr. (Mar 2025) to 1.25 Cr., marking an increase of 1.94 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.15. The value appears strong and on an upward trend. It has increased from -0.08 (Mar 2025) to 0.15, marking an increase of 0.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: September 15, 2025, 4:46 am

Growth

Last Updated: September 5, 2025, 9:20 am

Balance Sheet

Last Updated: August 11, 2025, 2:13 pm

Below is a detailed analysis of the balance sheet data for Kothari Sugars & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 83.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 83.00 Cr..
• For Reserves, as of Mar 2025, the value is 206.00 Cr.. The value appears strong and on an upward trend. It has increased from 196.00 Cr. (Mar 2024) to 206.00 Cr., marking an increase of 10.00 Cr..
• For Borrowings, as of Mar 2025, the value is 50.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 70.00 Cr. (Mar 2024) to 50.00 Cr., marking a decrease of 20.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 111.00 Cr.. The value appears to be improving (decreasing). It has decreased from 135.00 Cr. (Mar 2024) to 111.00 Cr., marking a decrease of 24.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 451.00 Cr.. The value appears to be improving (decreasing). It has decreased from 483.00 Cr. (Mar 2024) to 451.00 Cr., marking a decrease of 32.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 150.00 Cr.. The value appears to be declining and may need further review. It has decreased from 164.00 Cr. (Mar 2024) to 150.00 Cr., marking a decrease of 14.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 133.00 Cr.. The value appears strong and on an upward trend. It has increased from 100.00 Cr. (Mar 2024) to 133.00 Cr., marking an increase of 33.00 Cr..
• For Other Assets, as of Mar 2025, the value is 162.00 Cr.. The value appears to be declining and may need further review. It has decreased from 219.00 Cr. (Mar 2024) to 162.00 Cr., marking a decrease of 57.00 Cr..
• For Total Assets, as of Mar 2025, the value is 451.00 Cr.. The value appears to be declining and may need further review. It has decreased from 483.00 Cr. (Mar 2024) to 451.00 Cr., marking a decrease of 32.00 Cr..

Notably, the Reserves (206.00 Cr.) exceed the Borrowings (50.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Kothari Sugars & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 18, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 17) to 0.28, marking a decrease of 1.16.
• For Diluted EPS (Rs.), as of Mar 18, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 17) to 0.28, marking a decrease of 1.16.
• For Cash EPS (Rs.), as of Mar 18, the value is 1.71. This value is below the healthy minimum of 3. It has decreased from 3.06 (Mar 17) to 1.71, marking a decrease of 1.35.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.85. It has decreased from 17.41 (Mar 17) to 16.85, marking a decrease of 0.56.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.85. It has decreased from 17.41 (Mar 17) to 16.85, marking a decrease of 0.56.
• For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 34.62. It has decreased from 38.21 (Mar 17) to 34.62, marking a decrease of 3.59.
• For PBDIT / Share (Rs.), as of Mar 18, the value is 3.98. This value is within the healthy range. It has decreased from 5.05 (Mar 17) to 3.98, marking a decrease of 1.07.
• For PBIT / Share (Rs.), as of Mar 18, the value is 2.31. This value is within the healthy range. It has decreased from 3.29 (Mar 17) to 2.31, marking a decrease of 0.98.
• For PBT / Share (Rs.), as of Mar 18, the value is 0.30. This value is within the healthy range. It has decreased from 1.56 (Mar 17) to 0.30, marking a decrease of 1.26.
• For Net Profit / Share (Rs.), as of Mar 18, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 1.30 (Mar 17) to 0.04, marking a decrease of 1.26.
• For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 0.27. This value is below the healthy minimum of 2. It has decreased from 1.44 (Mar 17) to 0.27, marking a decrease of 1.17.
• For PBDIT Margin (%), as of Mar 18, the value is 11.50. This value is within the healthy range. It has decreased from 13.22 (Mar 17) to 11.50, marking a decrease of 1.72.
• For PBIT Margin (%), as of Mar 18, the value is 6.67. This value is below the healthy minimum of 10. It has decreased from 8.60 (Mar 17) to 6.67, marking a decrease of 1.93.
• For PBT Margin (%), as of Mar 18, the value is 0.86. This value is below the healthy minimum of 10. It has decreased from 4.08 (Mar 17) to 0.86, marking a decrease of 3.22.
• For Net Profit Margin (%), as of Mar 18, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 3.39 (Mar 17) to 0.11, marking a decrease of 3.28.
• For NP After MI And SOA Margin (%), as of Mar 18, the value is 0.79. This value is below the healthy minimum of 8. It has decreased from 3.77 (Mar 17) to 0.79, marking a decrease of 2.98.
• For Return on Networth / Equity (%), as of Mar 18, the value is 1.64. This value is below the healthy minimum of 15. It has decreased from 8.28 (Mar 17) to 1.64, marking a decrease of 6.64.
• For Return on Capital Employeed (%), as of Mar 18, the value is 9.11. This value is below the healthy minimum of 10. It has decreased from 11.54 (Mar 17) to 9.11, marking a decrease of 2.43.
• For Return On Assets (%), as of Mar 18, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 2.98 (Mar 17) to 0.60, marking a decrease of 2.38.
• For Long Term Debt / Equity (X), as of Mar 18, the value is 0.25. This value is within the healthy range. It has decreased from 0.37 (Mar 17) to 0.25, marking a decrease of 0.12.
• For Total Debt / Equity (X), as of Mar 18, the value is 0.73. This value is within the healthy range. It has decreased from 0.78 (Mar 17) to 0.73, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 18, the value is 0.73. It has decreased from 0.82 (Mar 17) to 0.73, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 18, the value is 1.07. This value is below the healthy minimum of 1.5. It has decreased from 1.14 (Mar 17) to 1.07, marking a decrease of 0.07.
• For Quick Ratio (X), as of Mar 18, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 17) to 0.29, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 18, the value is 1.47. This value is below the healthy minimum of 4. It has decreased from 1.92 (Mar 17) to 1.47, marking a decrease of 0.45.
• For Dividend Payout Ratio (NP) (%), as of Mar 18, the value is 217.73. This value exceeds the healthy maximum of 50. It has increased from 0.00 (Mar 17) to 217.73, marking an increase of 217.73.
• For Dividend Payout Ratio (CP) (%), as of Mar 18, the value is 30.89. This value is within the healthy range. It has increased from 0.00 (Mar 17) to 30.89, marking an increase of 30.89.
• For Earning Retention Ratio (%), as of Mar 18, the value is -117.73. This value is below the healthy minimum of 40. It has decreased from 0.00 (Mar 17) to -117.73, marking a decrease of 117.73.
• For Cash Earning Retention Ratio (%), as of Mar 18, the value is 69.11. This value is within the healthy range. It has increased from 0.00 (Mar 17) to 69.11, marking an increase of 69.11.
• For Interest Coverage Ratio (X), as of Mar 18, the value is 5.08. This value is within the healthy range. It has decreased from 5.16 (Mar 17) to 5.08, marking a decrease of 0.08.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 2.62. This value is below the healthy minimum of 3. It has decreased from 3.09 (Mar 17) to 2.62, marking a decrease of 0.47.
• For Enterprise Value (Cr.), as of Mar 18, the value is 116.17. It has decreased from 126.76 (Mar 17) to 116.17, marking a decrease of 10.59.
• For EV / Net Operating Revenue (X), as of Mar 18, the value is 0.40. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.40.
• For EV / EBITDA (X), as of Mar 18, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 3.03 (Mar 17) to 3.52, marking an increase of 0.49.
• For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.05.
• For Retention Ratios (%), as of Mar 18, the value is -117.73. This value is below the healthy minimum of 30. It has decreased from 0.00 (Mar 17) to -117.73, marking a decrease of 117.73.
• For Price / BV (X), as of Mar 18, the value is 0.11. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.11.
• For Price / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.05.
• For EarningsYield, as of Mar 18, the value is 0.13. This value is below the healthy minimum of 5. It has decreased from 0.72 (Mar 17) to 0.13, marking a decrease of 0.59.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness